Literature DB >> 22077064

Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

Nicole H Smith1, Eldad A Hod, Steven L Spitalnik, James C Zimring, Jeanne E Hendrickson.   

Abstract

Most human transfusion recipients fail to make detectable alloantibodies to foreign RBC antigens ("nonresponders"). Herein, we use a murine model to test the hypothesis that nonresponders may be immunologically tolerant. FVB mice transfused with RBCs expressing transgenic human glycophorin A (hGPA) antigen in the absence of inflammation produced undetectable levels of anti-hGPA immunoglobulins, unlike those transfused in the presence of polyinosinic:polycytidylic acid-induced inflammation. Mice in the nonresponder group failed to produce anti-hGPA after subsequent transfusions in the presence of polyinosinic:polycytidylic acid, whereas anti-hGPA levels increased in the responder group. This tolerance was antigen specific, because nonresponders to hGPA produced alloantibodies to RBCs that expressed a different transgenic antigen. This tolerance was not an idiosyncrasy of the hGPA antigen nor of the recipient strain, because B10.BR mice transfused with membrane-bound hen egg lysozyme antigen-transgenic RBCs also demonstrated induced nonresponsiveness. These data demonstrate that RBCs transfused in the absence of inflammation can induce tolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22077064      PMCID: PMC3286217          DOI: 10.1182/blood-2011-09-382655

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Detection of anti-D in D- recipients transfused with D+ red blood cells.

Authors:  Mark H Yazer; Darrell J Triulzi
Journal:  Transfusion       Date:  2007-08-21       Impact factor: 3.157

3.  Red blood cell alloimmunization in sickle cell disease patients in Uganda.

Authors:  Bernard Natukunda; Henk Schonewille; Christopher Ndugwa; Anneke Brand
Journal:  Transfusion       Date:  2009-10-10       Impact factor: 3.157

4.  Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice.

Authors:  I Auffray; S Marfatia; K de Jong; G Lee; C H Huang; C Paszty; M J Tanner; N Mohandas; J A Chasis
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

Review 5.  Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Authors:  Banu Aygun; Savitri Padmanabhan; Carole Paley; Visalam Chandrasekaran
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

6.  Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.

Authors:  John M Higgins; Steven R Sloan
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

7.  Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

Authors:  Jeanne E Hendrickson; Traci E Chadwick; John D Roback; Christopher D Hillyer; James C Zimring
Journal:  Blood       Date:  2007-06-25       Impact factor: 22.113

8.  Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.

Authors:  Christopher A Tormey; John Fisk; Gary Stack
Journal:  Transfusion       Date:  2008-07-09       Impact factor: 3.157

9.  Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice.

Authors:  Weili Bao; Jin Yu; Susanne Heck; Karina Yazdanbakhsh
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

10.  Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model.

Authors:  Maxime Desmarets; Chantel M Cadwell; Kenneth R Peterson; Renee Neades; James C Zimring
Journal:  Blood       Date:  2009-06-12       Impact factor: 22.113

View more
  25 in total

1.  Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Authors:  David R Gibb; Jingchun Liu; Prabitha Natarajan; Manjula Santhanakrishnan; David J Madrid; Stephanie C Eisenbarth; James C Zimring; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 2.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

3.  Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.

Authors:  Sean R Stowell; Kathryn R Girard-Pierce; Nicole H Smith; Kate L Henry; C Maridith Arthur; James C Zimring; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2013-04-29       Impact factor: 3.157

4.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

5.  Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Authors:  Rahma Elayeb; Marie Tamagne; Philippe Bierling; France Noizat-Pirenne; Benoît Vingert
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

6.  Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.

Authors:  Fernando Spiller; Corwin M Nycholat; Chika Kikuchi; James C Paulson; Matthew S Macauley
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

Review 7.  Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.

Authors:  Carlos H Villa; Douglas B Cines; Don L Siegel; Vladimir Muzykantov
Journal:  Transfus Med Rev       Date:  2016-08-17

8.  Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.

Authors:  Carla L Dinardo; Shannon Kelly; Marcia R Dezan; Ingrid H Ribeiro; Shirley L Castilho; Luciana C Schimidt; Maria do C Valgueiro; Liliana R Preiss; Brian Custer; Ester C Sabino; Connie M Westhoff
Journal:  Transfusion       Date:  2019-08-13       Impact factor: 3.157

9.  Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.

Authors:  Dong Liu; David R Gibb; Vicente Escamilla-Rivera; Jingchun Liu; Manjula Santhanakrishnan; Zhimin Shi; Lan Xu; Stephanie C Eisenbarth; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-08-12       Impact factor: 3.157

10.  Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease.

Authors:  Weili Bao; Hui Zhong; Deepa Manwani; Ljiljana Vasovic; Joan Uehlinger; Margaret T Lee; Sujit Sheth; Patricia Shi; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.